Prediction of early death among patients (pts) enrolled in phase I trials: Development and validation of a new model based on platelet count and albumin level. A multicenter phase II neoadjuvant trial ...

Most patients (56%) had low A1c variability (0%-0.49% per quarter), and about one third had moderate variability (0.5%-1%). The lowest risk for the outcomes of MI ...

Matsushita Electric Industrial Co. Ltd. said it is using Mentor Graphics Corp.’s Calibre OPCverify design-for-manufacturing (DFM) software for use in production at 65nm and below to examine the impact ...

Step 1 Select between 20 to 30 test samples that represent the full range of variation encountered in actual production runs.

Repeatable tumor measurements are key to accurately assessing tumor growth and treatment efficacy. A preliminary study that we conducted showed that a novel 3D and thermal imaging system (3D-TI) for ...